Abstract:Objective To evaluated the clinical outcomes of periprosthetic joint infection (PJI) patients with destination joint spacer compared with that of two‐stage revision. Methods From January 2006 to December 2017, data of PJI patients who underwent implantation with antibiotic‐impregnated cement spacers in our center due to chronic PJI were collected retrospectively. The diagnosis of PJI was based on the American Society for Musculoskeletal Infection (MSIS) criteria for PJI. One of the following must be met for diagnosis of PJI: a sinus tract communicating with the prosthesis; a pathogenis isolated by culture from two separate tissue or fluid samples obtained from the affected prosthetic joint; four of the following six criteria exist: (i) elevated ESR and CRP; (ii) elevate dsynovial fluid white blood cell (WBC) count; (iii) elevated synovial fluid neutrophil percentage (PMN%); (iv) presence of purulence in the affected joint; (v) isolation of a microorganism in one periprosthetic tissue or fluid culture; (vi) more than five neutrophilsper high‐power fields in five high‐power fields observed from histological analysis of periprosthetic tissue at ×400 magnification. Age, sex, body mass index (BMI), and laboratory test results were recorded. All patients were followed up regularly after surgery, the infection‐relief rates were recorded, Harris hip score (HHS) and knee society score (KSS) were used for functional evaluation, a Doppler ultrasonography of the lower limb veins was performed for complication evaluation. The infection‐relief rates and complications were compared between destination joint spacer group and two‐stage revision group. Results A total of 62 patients who were diagnosed with chronic PJI were enrolled, with an age of 65.13 ± 9.94 (39–88) years. There were 21 cases in the destination joint spacer group and 41 cases in the temporary spacer group, namely, two‐stage revision group (reimplantation of prosthesis after infection relief). The Charlson comorbidity index (CCI) in the destination joint spacer group was higher than that in the temporary spacer group, and this might be the primary reason for joint spacer retainment. As for infection‐relief rate, there were three cases of recurrent infection (14.29%) in the destination joint spacer group and four cases of recurrent infection (9.76%) in the two‐stage revision group, there were no significant differences with regard to infection‐relief rate. Moreover, there two patients who suffered from spacer fractures, three cases of dislocation, one case of a periarticular fracture, and three cases of deep venous thrombosis in destination joint spacer group, while there was only one case of periprosthetic hip joint fracture, one case of dislocation, and one patient suffered from deep venous thrombosis of the lower extremity in two‐stage revision. The incidence of complications in the destination joint spacer group was higher than that of two‐stage revision. Conclusions In summary, the present work showed that a destination joint spacer might be provided as a last resort for certain PJI patients due to similar infection‐relief rate compared with two‐stage revision.

Preliminary Application of Provisional Prosthesis in the Treatment of Infection after Hip Replacement

Partial Two?stage Exchange for Periprosthetic Joint Infection after Total Hip Arthroplasty

Partial Two-Stage Exchange: an Alternative Method for Infected Total Hip Arthroplasty

Related factors and intervention analysis of periprosthetic infections in patients with total hip arthroplasty

Treatment of Infection after Hip Arthroplasty by Spacer-Free Two-Stage Revision

Application of antibiotic-loaded bone cement spacer in second-stage revision for infected total hip arthroplasty

Functional Outcome after Reimplantation in Patients Treated with and without an Antibiotic-Loaded Cement Spacers for Hip Prosthetic Joint Infections

Treatment of Infection after Hip Arthroplasty Using Antibiotic-Impregnated Cement Spacer by Two-Stage Exchange Arthroplasty

Clinical progress of cemented prosthesis as spacer inserted in two-stage revision for periprosthetic joint infection following total hip arthroplasty

[Two-stage total hip arthroplasty using an antibiotic-loaded cement spacer for infected internal fixation of hip fractures]

Medium term outcomes of treatment using antibiotic articulating cement spacers for prosthetic hip infection

Treatment of Postprosthesis Infection by Revision Total Hip Arthroplasty

Commercially manufactured spacers for the treatment of periprosthetic joint infection of the hip

Destination Joint Spacers: A Similar Infection‐Relief Rate but Higher Complication Rate Compared with Two‐Stage Revision

Management of the infected total hip or knee arthroplasty with two-staged revisions

Use of 1.5-Stage Functional Articulating Hip Spacers for Two-stage Treatment of Hip Infection

Treatment of infectious hip arthritis with optimized articulating medullary-sparing spacer

Application of an articulating spacer in two-stage revision for severe infection after total knee arthroplasty.

Prosthetic spacers in two-stage revision for knee periprosthetic joint infection achieve better function and similar infection control

[Cementless Two-Staged Total Hip Arthroplasty for Chronic Periprosthetic Infection].

Novel Articulating Medullary-Sparing Spacer for the Treatment of Infectious Hip Arthritis.